The Phase 1 trial is to assess the tolerability and pharmacokinetics of arbaclofen placarbil [XP 19986; XenoPort].
Phase of Trial: Phase I
Latest Information Update: 13 Nov 2007
At a glance
- Drugs Arbaclofen placarbil (Primary)
- Indications Gastro-oesophageal reflux
- Focus Adverse reactions; Pharmacokinetics
- Sponsors XenoPort
- 13 Nov 2007 New trial record.